New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

NCT00001335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Ewing's Sarcoma
Neuroblastoma
Rhabdomyosarcoma

Interventions

DRUG: ADR-529
DRUG: Topotecan
DRUG: G-CSF

Sponsor

National Cancer Institute (NCI)